Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Applied Bio

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 17 November 1995:
Vol. 270. no. 5239, pp. 1194 - 1197
DOI: 10.1126/science.270.5239.1194
Prev | Table of Contents | Next

Reports

Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS

William G. Rice (1),  Jeffrey G. Supko,  Louis Malspeis,  Robert W. Buckheit Jr.,  David Clanton,  Ming Bu,  Lisa Graham,  Catherine A. Schaeffer,  Jim A. Turpin,  John Domagala,  Rocco Gogliotti,  John P. Bader,  Susan M. Halliday,  Lori Coren,  Raymond C. Sowder II,  Larry O. Arthur,  Louis E. Henderson

Strategies for the treatment of human immunodeficiency virus-type 1 (HIV-1) infection must contend with the obstacle of drug resistance. HIV-1 nucleocapsid protein zinc fingers are prime antiviral targets because they are mutationally intolerant and are required both for acute infection and virion assembly. Nontoxic disulfide-substituted benzamides were identified that attack the zinc fingers, inactivate cell-free virions, inhibit acute and chronic infections, and exhibit broad antiretroviral activity. The compounds were highly synergistic with other antiviral agents, and resistant mutants have not been detected. Zinc finger-reactive compounds may offer an anti-HIV strategy that restricts drug-resistance development.


W. G. Rice, M. Bu, L. Graham, C. A. Schaeffer, J. A. Turpin, Laboratory of Antiviral Drug Mechanisms, PRI/DynCorp, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA.
J. G. Supko and L. Malspeis, Laboratory of Pharmaceutical Chemistry, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Frederick, MD 21701-8527, USA.
R. W. Buckheit Jr. and S. M. Halliday, Virology Research Group, Southern Research Institute-Frederick Research Center, Frederick, MD 21701, USA.
D. Clanton, Anti-AIDS Virus Drug Screening Laboratory, PRI/DynCorp, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA.
J. Domagala and R. Gogliotti, Chemistry Department, Parke-Davis Pharmaceutical Research Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA.
J. P. Bader, Antiviral Evaluations Branch, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20892, USA.
L. Coren, R. C. Sowder II, L. O. Arthur, L. E. Henderson, AIDS Vaccine Program, PRI/DynCorp, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA.
(1) To whom correspondence should be addressed.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Cysteine 155 plays an important role in the assembly of Mycobacterium tuberculosis FtsZ.
R. Jaiswal and D. Panda (2008)
Protein Sci. 17, 846-854
   Abstract »    Full Text »    PDF »
Nucleocapsid mutations turn HIV-1 into a DNA-containing virus.
L. Houzet, Z. Morichaud, L. Didierlaurent, D. Muriaux, J.-L. Darlix, and M. Mougel (2008)
Nucleic Acids Res. 36, 2311-2319
   Abstract »    Full Text »    PDF »
Development of a Cell-Based Assay Probing the Specific Interaction between the Human Immunodeficiency Virus Type 1 Nucleocapsid and Psi RNA In Vivo.
S. I. Jang, Y. H. Kim, S. Y. Paik, and J. C. You (2007)
J. Virol. 81, 6151-6155
   Abstract »    Full Text »    PDF »
Methylisothiazolinone, A Neurotoxic Biocide, Disrupts the Association of Src Family Tyrosine Kinases with Focal Adhesion Kinase in Developing Cortical Neurons.
K. He, J. Huang, C. F. Lagenaur, and E. Aizenman (2006)
J. Pharmacol. Exp. Ther. 317, 1320-1329
   Abstract »    Full Text »    PDF »
Inhibitory effects of archetypical nucleic acid ligands on the interactions of HIV-1 nucleocapsid protein with elements of {Psi}-RNA.
K. B. Turner, N. A. Hagan, and D. Fabris (2006)
Nucleic Acids Res. 34, 1305-1316
   Abstract »    Full Text »    PDF »
Inactivation of Retroviruses with Preservation of Structural Integrity by Targeting the Hydrophobic Domain of the Viral Envelope.
Y. Raviv, M. Viard, J. W Bess Jr., E. Chertova, and R. Blumenthal (2005)
J. Virol. 79, 12394-12400
   Abstract »    Full Text »    PDF »
Elimination of Retroviral Infectivity by N-Ethylmaleimide with Preservation of Functional Envelope Glycoproteins.
D. R. Morcock, J. A. Thomas, T. D. Gagliardi, R. J. Gorelick, J. D. Roser, E. N. Chertova, J. W. Bess Jr., D. E. Ott, Q. J. Sattentau, I. Frank, et al. (2005)
J. Virol. 79, 1533-1542
   Abstract »    Full Text »    PDF »
Inhibition of Invasion and Angiogenesis by Zinc-Chelating Agent Disulfiram.
S.-G. Shian, Y.-R. Kao, F. Y.-H. Wu, and C.-W. Wu (2003)
Mol. Pharmacol. 64, 1076-1084
   Abstract »    Full Text »    PDF »
G-quartets direct assembly of HIV-1 nucleocapsid protein along single-stranded DNA.
S. Lyonnais, R. J. Gorelick, J.-L. Mergny, E. Le Cam, and G. Mirambeau (2003)
Nucleic Acids Res. 31, 5754-5763
   Abstract »    Full Text »    PDF »
Evidence for the Differential Effects of Nucleocapsid Protein on Strand Transfer in Various Regions of the HIV Genome.
S. S. Derebail, M. J. Heath, and J. J. DeStefano (2003)
J. Biol. Chem. 278, 15702-15712
   Abstract »    Full Text »    PDF »
Reversal by Dithiothreitol Treatment of the Block in Murine Leukemia Virus Maturation Induced by Disulfide Cross-Linking.
S. Campbell, M. Oshima, J. Mirro, K. Nagashima, and A. Rein (2002)
J. Virol. 76, 10050-10055
   Abstract »    Full Text »    PDF »
Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design.
I. A. Topol, C. McGrath, E. Chertova, C. Dasenbrock, W. R. Lacourse, M. A. Eissenstat, S. K. Burt, L. E. Henderson, and J. R. Casas-Finet (2001)
Protein Sci. 10, 1434-1445
   Abstract »    Full Text »    PDF »
Human Immunodeficiency Virus and AIDS: Insights from Animal Lentiviruses.
R. J. Miller, J. S. Cairns, S. Bridges, and N. Sarver (2000)
J. Virol. 74, 7187-7195
   Full Text »
Identification of a Key Target Sequence To Block Human Immunodeficiency Virus Type 1 Replication within the gag-pol Transframe Domain.
S. Sei, Q.-e. Yang, D. O'Neill, K. Yoshimura, K. Nagashima, and H. Mitsuya (2000)
J. Virol. 74, 4621-4633
   Abstract »    Full Text »
Inactivation of HIV-1 Nucleocapsid Protein P7 by Pyridinioalkanoyl Thioesters. CHARACTERIZATION OF REACTION PRODUCTS AND PROPOSED MECHANISM OF ACTION.
V. Basrur, Y. Song, S. J. Mazur, Y. Higashimoto, J. A. Turpin, W. G. Rice, J. K. Inman, and E. Appella (2000)
J. Biol. Chem. 275, 14890-14897
   Abstract »    Full Text »    PDF »
Zinc-Altered Immune Function and Cytokine Production.
L. Rink and H. Kirchner (2000)
J. Nutr. 130, 1407S-1411
   Abstract »    Full Text »
The Function of Zinc Metallothionein: A Link between Cellular Zinc and Redox State.
W. Maret (2000)
J. Nutr. 130, 1455S-1458
   Abstract »    Full Text »
Nucleic Acid Binding Properties of the Simian Immunodeficiency Virus Nucleocapsid Protein NCp8.
M. A. Urbaneja, C. F. McGrath, B. P. Kane, L. E. Henderson, and J. R. Casas-Finet (2000)
J. Biol. Chem. 275, 10394-10404
   Abstract »    Full Text »    PDF »
Multiple Effects of an Anti-Human Immunodeficiency Virus Nucleocapsid Inhibitor on Virus Morphology and Replication.
L. Berthoux, C. Péchoux, and J.-L. Darlix (1999)
J. Virol. 73, 10000-10009
   Abstract »    Full Text »
Human Immunodeficiency Virus Type 1 Gag Polyprotein Multimerization Requires the Nucleocapsid Domain and RNA and Is Promoted by the Capsid-Dimer Interface and the Basic Region of Matrix Protein.
M. T. Burniston, A. Cimarelli, J. Colgan, S. P. Curtis, and J. Luban (1999)
J. Virol. 73, 8527-8540
   Abstract »    Full Text »    PDF »
Potential Drugs Against Cervical Cancer: Zinc-Ejecting Inhibitors of the Human Papillomavirus Type 16 E6 Oncoprotein.
W. Beerheide, H.-U. Bernard, Y.-J. Tan, A. Ganesan, W. G. Rice, and A. E. Ting (1999)
J Natl Cancer Inst 91, 1211-1220
   Abstract »    Full Text »    PDF »
A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
S. Druillennec, C. Z. Dong, S. Escaich, N. Gresh, A. Bousseau, B. P. Roques, and M. C. Fournie-Zaluski (1999)
PNAS 96, 4886-4891
   Abstract »    Full Text »    PDF »
The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.
M. E. Garber, P. Wei, V. N. KewalRamani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones (1998)
Genes & Dev. 12, 3512-3527
   Abstract »    Full Text »
Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins.
J. L. Rossio, M. T. Esser, K. Suryanarayana, D. K. Schneider, J. W. Bess Jr., G. M. Vasquez, T. A. Wiltrout, E. Chertova, M. K. Grimes, Q. Sattentau, et al. (1998)
J. Virol. 72, 7992-8001
   Abstract »    Full Text »    PDF »
Actinomycin D Inhibits Human Immunodeficiency Virus Type 1 Minus-Strand Transfer in In Vitro and Endogenous Reverse Transcriptase Assays.
J. Guo, T. Wu, J. Bess, L. E. Henderson, and J. G. Levin (1998)
J. Virol. 72, 6716-6724
   Abstract »    Full Text »    PDF »
A cobalt complex that selectively disrupts the structure and function of zinc fingers.
A. Y. Louie and T. J. Meade (1998)
PNAS 95, 6663-6668
   Abstract »    Full Text »    PDF »
Efficacies of Zinc-Finger-Active Drugs against Giardia lamblia.
T. Nash and W. G. Rice (1998)
Antimicrob. Agents Chemother. 42, 1488-1492
   Abstract »    Full Text »
Inhibition of Acute-, Latent-, and Chronic-Phase Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Bistriazoloacridone Analog That Selectively Inhibits HIV-1 Transcription.
J. A. Turpin, R. W. Buckheit Jr., D. Derse, M. Hollingshead, K. Williamson, C. Palamone, M. C. Osterling, S. A. Hill, L. Graham, C. A. Schaeffer, et al. (1998)
Antimicrob. Agents Chemother. 42, 487-494
   Abstract »    Full Text »
Structure of the HIV-1 Nucleocapsid Protein Bound to the SL3 Psi -RNA Recognition Element.
R. N. De Guzman, Z. R. Wu, C. C. Stalling, L. Pappalardo, P. N. Borer, and M. F. Summers (1998)
Science 279, 384-388
   Abstract »    Full Text »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)